ADORINI; Luciano

Patent Applications and Registrations

Patent applications and USPTO patent grants for ADORINI; Luciano.The latest application filed is for "pharmaceutical compositions for combination therapy".

Company Profile

1.3.23

ADORINI; Luciano - Milano IT
Adorini; Luciano - Milan IT
Adorini, Luciano - Via Righi IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions For Combination Therapy App 20220280533 - PRUZANSKI; Mark ; et al.	2022-09-08
Pharmaceutical Compositions For Combination Therapy App 20220280534 - PRUZANSKI; Mark ; et al.	2022-09-08
Pharmaceutical compositions for combination therapy Grant 11,311,557 - Pruzanski , et al. April 26, 2	2022-04-26
FXR agonist compositions for combination therapy Grant 10,894,054 - Pruzanski , et al. January 19, 2	2021-01-19
Pharmaceutical Compositions Of A Bile Acid Derivative And Microbiome And Uses Thereof App 20200164005 - Wu; Gary D ; et al.	2020-05-28
Pharmaceutical Compositions For Combination Therapy App 20180117065 - PRUZANSKI; Mark ; et al.	2018-05-03
Treatment of Pulmonary Disease App 20180064729 - Pruzanski; Mark ; et al.	2018-03-08
Methods For Modulating Bone Density App 20180042943 - Shapiro; David ; et al.	2018-02-15
Pharmaceutical Compositions For Combination Therapy App 20180008616 - Pruzanski; Mark ; et al.	2018-01-11
Treatment of Pulmonary Disease App 20160213689 - Pruzanski; Mark ; et al.	2016-07-28
Treatment of Pulmonary Disease App 20140148428 - Pruzanski; Mark ; et al.	2014-05-29
Novel Method Of Treatment Of Male Sub-fertility App 20100069339 - Adorini; Luciano ; et al.	2010-03-18
Novel Method App 20100009949 - Adorini; Luciano	2010-01-14
Methods of Treating Osteoporosis and Secondary Hyperparathyroidism Using 20-Methyl, Gemini Vitamin D3 Compounds App 20090298799 - Adorini; Luciano ; et al.	2009-12-03
1,25-dihydroxy, 20-cyclopropyl,26-27-deuteroalkyl Vitamin D3 Compounds And Methods Of Use Thereof App 20090298800 - Uskokovic; Milan R. ; et al.	2009-12-03
20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof App 20090099140 - Jankowski; Pawel ; et al.	2009-04-16
20-Cyclopropyl, 26,27-Alkyl/Haloalkyl Vitamin D3 Compounds and Methods of Use Thereof App 20080318911 - Uskokovic; Milan R. ; et al.	2008-12-25
Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer App 20080293647 - Adorini; Luciano ; et al.	2008-11-27
Gemini Vitamin D3 Compounds And Methods Of Use Thereof App 20080280859 - Adorini; Luciano ; et al.	2008-11-13
Method for treating benign prostatic hyperplasia App 20080207769 - Adorini; Luciano ; et al.	2008-08-28
1,3-Diacylated, 26,27-Alkyl/Haloakyl Vitamin D3 Compounds and Methods of Use Thereof App 20080064668 - Uskokovic; Milan R. ; et al.	2008-03-13
Method for treating benign prostatic hyperplasia Grant 7,332,482 - Adorini , et al. February 19, 2	2008-02-19
1,3 Aclyated 24-keto-vitamin d3 compounds and methods of use thereof App 20070032461 - Adorini; Luciano ; et al.	2007-02-08
Method for the prevention and treatment of uveitis App 20060258630 - Adorini; Luciano	2006-11-16
Method for treating benign prostatic hyperplasia App 20050065124 - Adorini, Luciano ; et al.	2005-03-24
Use of vitamin d3 analogue for the treatment of autoimmune diabetes App 20040214803 - Adorini, Luciano ; et al.	2004-10-28

Company Registrations

SEC

0001559512

Adorini Luciano

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.